SADI-S Bariatric Surgery: Clinical Overview
What is SADI-S?
SADI-S (Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy) is an effective malabsorptive bariatric procedure that combines a sleeve gastrectomy with a single duodeno-ileal anastomosis, though it remains under review by the American Society for Metabolic and Bariatric Surgery (ASMBS) and has not been endorsed as a primary procedure due to lack of robust long-term follow-up data. 1
The procedure involves creating a larger-volume sleeve gastrectomy than a standard sleeve, followed by duodenal transection and a loop duodenoileostomy. The common channel (alimentary limb from anastomosis to colon) typically measures 150-300 cm, with optimal outcomes requiring a common channel length of at least 250 cm to prevent malnutrition and excessive gastrointestinal symptoms 2.
Indications
Primary SADI-S Indications:
- BMI ≥35 kg/m² regardless of comorbidities 3
- BMI 30-34.9 kg/m² with metabolic disease (non-Asian patients) 3
- BMI ≥27.5 kg/m² with metabolic disease (Asian patients) 3
- Particularly effective for patients age 70 years and older when compared to gastric banding and RYGB 1
- Severe obesity with BMI ≥60 kg/m² requiring maximal weight loss 4
Secondary/Revisional SADI-S Indications:
- Inadequate weight loss or weight regain after sleeve gastrectomy 5, 6
- Failed sleeve gastrectomy requiring conversion 5
Contraindications:
- Active GERD or hiatal hernia (though some centers perform SADI-S with fundoplication for GERD in severe obesity) 1
- Inability to comply with lifelong nutritional monitoring
- Active substance abuse requiring documented abstinence 7
Expected Outcomes
Weight Loss Results:
Primary SADI-S achieves superior weight loss compared to secondary procedures:
- Mean total weight loss (TWL) at 5 years: 34.8% for primary vs 15.9% for secondary SADI-S 2
- At 12 months: ≥25% TWL 8
- At 24 months: >44% TWL 8
- Excess weight loss (EWL): 47.73% at 6 months, 59.39% at 12 months, and sustained results at 24 months 5
- Common channel ≤250 cm produces 25.3% TWL vs 21.3% for >250 cm at 5 years 2
These results are comparable to BPD-DS (biliopancreatic diversion with duodenal switch) with a trend toward fewer nutritional deficiencies at 3-5 year follow-up 1, 8.
Comorbidity Resolution:
SADI-S demonstrates excellent metabolic outcomes:
- Type 2 diabetes remission: 63-75.8% 8, 5
- Hypertension resolution: 48-61.2% 8, 5
- Dyslipidemia resolution: 55-60.4% 8, 5
- Obstructive sleep apnea resolution: 71.9% 8
Quality of Life:
Patients undergoing primary SADI-S show significantly higher health-related quality of life scores across all BODY-Q domains except sexual well-being compared to secondary procedures 2.
Risks and Complications
Early Complications (30-day):
Overall complication rate: 2.5-10.4% 6, 4
- Anastomotic leak: 0.6-1% (lower than expected) 5, 4
- Postoperative bleeding: 1-10.4% (most managed conservatively) 6, 4
- Intra-abdominal abscess: 0.4% 4
- Skin/soft tissue infection (most common complication) 9
- Unplanned ICU admission 9
Risk factors for complications:
- Longer operative time (independently associated with complications) 4
- Increased estimated blood loss (independently associated with complications) 4
- Primary vs revisional status does NOT significantly affect complication rates 6, 4
Mortality: 0.1% (consistent with overall bariatric surgery mortality) 3
Late Complications:
Nutritional Deficiencies:
- Total protein and albumin deficiency 8
- Folate deficiency 8
- Vitamin B12 deficiency 8
- Vitamin D deficiency 8
- Risk decreases with common limb length ≥250-300 cm 8
Gastrointestinal Symptoms:
- Postoperative diarrhea: 2% (relatively low) 5
- Daily diarrhea more common with common channel ≤250 cm 2
- GERD rates comparable between primary and secondary procedures 6
Preoperative Management
Multidisciplinary Evaluation:
All patients require comprehensive assessment by:
- Bariatric surgeon
- Specialist dietitian skilled in bariatric nutrition 10
- Mental health professional 11
- Additional specialists as indicated by comorbidities
Mandatory Preoperative Laboratory Testing:
Essential screening (Grade B-D recommendations): 10
- Complete blood count (hemoglobin, ferritin, folate, B12)
- 25-hydroxyvitamin D levels
- Serum calcium
- Parathyroid hormone (PTH)
- HbA1c
- Lipid profile
- Liver function tests
- Renal function tests
Additional testing for malabsorptive procedures like SADI-S (GPP recommendations): 10
- Vitamin A levels
- Zinc, copper, and selenium levels
- Consider thiamine if deficiency suspected
Nutritional Optimization:
- Correct all identified nutritional deficiencies preoperatively 10
- Multivitamin/mineral supplementation during preoperative low-calorie diet 10
- Many centers recommend low-calorie/low-carbohydrate diet immediately before surgery to reduce liver size 10
Behavioral Modifications:
Smoking cessation:
- Mandatory cessation at least 4-8 weeks before surgery 7
- Weekly counseling plus nicotine replacement therapy recommended 7
- Reduces marginal ulcers, infectious complications, and respiratory complications 7
Alcohol cessation:
- 1-2 years documented abstinence required for patients with previous overconsumption 7
- Reduces postoperative infectious and wound healing complications 7
Imaging:
No routine preoperative imaging required 3
Selective imaging indications:
- Significant GI symptoms → biphasic esophagram 3
- Biliary symptoms → abdominal ultrasound
- Elevated liver function tests → abdominal imaging 3
- Suspected hiatal hernia or GERD → esophagram (may alter surgical plan) 3
Surgical Technique Considerations
Technical Details:
- Bougie size: 50Fr for primary SADI-S sleeve component 6
- Common channel length: MUST be ≥250 cm (preferably 250-300 cm) to minimize malnutrition and diarrhea 2, 8
- Duodeno-ileal anastomosis: at least 2 cm distal to pylorus 6
- Measured from ileocecal valve: 250 cm 6
Operative Approach:
- Laparoscopic or robotic-assisted approach 12, 9
- Robotic platform use increased from 33.4% to 41.0% (2020-2023) 9
- Mean operative time: 125.98-181 minutes 5, 12
Postoperative Management
Immediate Postoperative Care:
Early nutrition:
- Clear liquid diet can be initiated several hours after surgery 7
- High-protein formula recommended 13
- Avoid standard oral supplements with high glucose (risk of dumping syndrome) 13
- Target: 60 g protein/day 13
Thromboprophylaxis:
- Mechanical and pharmacological measures individualized by patient risk 7
Acid suppression:
- PPI prophylaxis for at least 30 days (moderate evidence for RYGB, extrapolated to SADI-S) 7
Gallstone prevention:
- Ursodeoxycholic acid for 6 months for patients without preoperative gallstones 7
Nutritional Monitoring and Supplementation:
Lifelong vitamin and mineral supplementation is MANDATORY 7
Required monitoring schedule:
- Comprehensive nutritional biochemical monitoring at regular intervals 10, 7
- More frequent monitoring than restrictive procedures due to malabsorptive component
Critical micronutrients requiring supplementation and monitoring:
- Thiamine (especially critical in early postoperative period - risk of Wernicke's encephalopathy) 7
- Vitamin B12
- Folate
- Iron
- Vitamin D and calcium (for bone health)
- Vitamin A
- Vitamin E
- Vitamin K
- Zinc
- Copper
- Selenium
- Total protein and albumin
Follow-up Schedule:
- Dedicated bariatric team follow-up 13, 11
- Ideally every 4-6 weeks initially 11
- Dietary counseling to support lifestyle changes 7
- Monitor weight loss trajectory
- Screen for and address micronutrient deficiencies
- Physical activity >200 min/week often required for weight maintenance 11
Critical Pitfalls to Avoid
Common channel <250 cm: Results in excessive malnutrition and diarrhea 2, 8
Inadequate preoperative nutritional assessment: Patients already have high rates of vitamin D deficiency (up to 99%), iron deficiency (up to 47%), and other deficiencies that worsen postoperatively 10
Failure to ensure lifelong nutritional monitoring: This is a malabsorptive procedure requiring permanent supplementation and surveillance 7
Performing SADI-S in patients with active GERD without addressing reflux: Contraindication unless combined with fundoplication 1
Inadequate patient education about permanent dietary changes: Patients must understand this is not reversible and requires lifelong commitment 7
Ignoring thiamine supplementation in early postoperative period: High risk of Wernicke's encephalopathy 7
Using standard high-glucose oral supplements postoperatively: Risk of dumping syndrome 13
Current Status and Limitations
SADI-S has NOT been endorsed by ASMBS as a primary procedure due to lack of robust long-term follow-up data beyond 5 years 1. However, mid-term data (3-5 years) show:
- Safety comparable to BPD-DS 1
- Effectiveness equal to or better than BPD-DS 8
- Trend toward fewer nutritional deficiencies than BPD-DS 1
- Volume increased 4-fold from 2020-2023 without increase in complication rates 9
The procedure should be performed by experienced bariatric surgeons in accredited centers with comprehensive multidisciplinary support and commitment to lifelong patient follow-up 4, 9.